Proteros is a biotech company focused on enabling lead discovery for challenging targets. Proteros has established a profitable discovery service business with a best-in-class enabling technology platform for structure accelerated lead discovery. Their track record is proven by an outstanding project success rate. Proteros’ proprietary pipelineincludes highly disease relevant target classes such as kinases, epigenetic targets and GPCRs. Their success is built on unique know how and expertise in understanding the role of protein structures involved in protein and small molecule interactions that are responsible for the pathogenesis of many diseases.

Biotechnology

Proteros

Torsten Neuefeind

Andrew Neville

Steven L. Holshouser

George Buckley

Dr. Tanja Vukicevic

Peter Persigehl

Research and Development Team

Leadership Team

Proteros

Org chart

Teams

Research and Development Team

Leadership Team

Offices

Similar companies